Goldschmidt H - Search Results

1

Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.

Tirier SM, Mallm JP, Steiger S, Poos AM, Awwad MHS, Giesen N, Casiraghi N, Susak H, Bauer K, Baumann A, John L, Seckinger A, Hose D, Müller-Tidow C, Goldschmidt H, Stegle O, Hundemer M, Weinhold N, Raab MS, Rippe K. Tirier SM, et al. Among authors: goldschmidt h. Nat Commun. 2021 Nov 29;12(1):6960. doi: 10.1038/s41467-021-26951-z. Nat Commun. 2021. PMID: 34845188 Free PMC article.

2

Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.

Choi C, Witzens M, Bucur M, Feuerer M, Sommerfeldt N, Trojan A, Ho A, Schirrmacher V, Goldschmidt H, Beckhove P. Choi C, et al. Among authors: goldschmidt h. Blood. 2005 Mar 1;105(5):2132-4. doi: 10.1182/blood-2004-01-0366. Epub 2004 Nov 23. Blood. 2005. PMID: 15561890 Free article.

3

High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.

Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, Linke RP, Ho AD, Goldschmidt H. Perz JB, et al. Among authors: goldschmidt h. Br J Haematol. 2004 Dec;127(5):543-51. doi: 10.1111/j.1365-2141.2004.05232.x. Br J Haematol. 2004. PMID: 15566357 Free article. Clinical Trial.

4

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.

Mahtouk K, Hose D, Rème T, De Vos J, Jourdan M, Moreaux J, Fiol G, Raab M, Jourdan E, Grau V, Moos M, Goldschmidt H, Baudard M, Rossi JF, Cremer FW, Klein B. Mahtouk K, et al. Among authors: goldschmidt h. Oncogene. 2005 May 12;24(21):3512-24. doi: 10.1038/sj.onc.1208536. Oncogene. 2005. PMID: 15735670 Free PMC article.

5

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.

Moreaux J, Cremer FW, Reme T, Raab M, Mahtouk K, Kaukel P, Pantesco V, De Vos J, Jourdan E, Jauch A, Legouffe E, Moos M, Fiol G, Goldschmidt H, Rossi JF, Hose D, Klein B. Moreaux J, et al. Among authors: goldschmidt h. Blood. 2005 Aug 1;106(3):1021-30. doi: 10.1182/blood-2004-11-4512. Epub 2005 Apr 12. Blood. 2005. PMID: 15827134 Free PMC article.

6

Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.

Cremer FW, Bila J, Buck I, Kartal M, Hose D, Ittrich C, Benner A, Raab MS, Theil AC, Moos M, Goldschmidt H, Bartram CR, Jauch A. Cremer FW, et al. Among authors: goldschmidt h. Genes Chromosomes Cancer. 2005 Oct;44(2):194-203. doi: 10.1002/gcc.20231. Genes Chromosomes Cancer. 2005. PMID: 16001433

7

Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.

Lotz C, Mutallib SA, Oehlrich N, Liewer U, Ferreira EA, Moos M, Hundemer M, Schneider S, Strand S, Huber C, Goldschmidt H, Theobald M. Lotz C, et al. Among authors: goldschmidt h. J Immunol. 2005 Jul 15;175(2):1301-9. doi: 10.4049/jimmunol.175.2.1301. J Immunol. 2005. PMID: 16002735

8

High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.

Cremer FW, Kartal M, Hose D, Bila J, Buck I, Bellos F, Raab MS, Brough M, Moebus A, Hager HD, Goldschmidt H, Moos M, Bartram CR, Jauch A. Cremer FW, et al. Among authors: goldschmidt h. Cancer Genet Cytogenet. 2005 Sep;161(2):116-24. doi: 10.1016/j.cancergencyto.2005.02.015. Cancer Genet Cytogenet. 2005. PMID: 16102581

9

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis.

Schonland SO, Perz JB, Hundemer M, Hegenbart U, Kristen AV, Hund E, Dengler TJ, Beimler J, Zeier M, Singer R, Linke RP, Ho AD, Goldschmidt H. Schonland SO, et al. Among authors: goldschmidt h. Transplantation. 2005 Sep 27;80(1 Suppl):S160-3. doi: 10.1097/01.tp.0000186902.57687.8d. Transplantation. 2005. PMID: 16286897

10

Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.

Hundemer M, Schmidt S, Condomines M, Lupu A, Hose D, Moos M, Cremer F, Kleist C, Terness P, Belle S, Ho AD, Goldschmidt H, Klein B, Christensen O. Hundemer M, et al. Among authors: goldschmidt h. Exp Hematol. 2006 Apr;34(4):486-96. doi: 10.1016/j.exphem.2006.01.008. Exp Hematol. 2006. PMID: 16569595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

816 results

Search Page